Tom Ehlen

3.7k total citations · 1 hit paper
15 papers, 2.3k citations indexed

About

Tom Ehlen is a scholar working on Reproductive Medicine, Epidemiology and Obstetrics and Gynecology. According to data from OpenAlex, Tom Ehlen has authored 15 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Reproductive Medicine, 5 papers in Epidemiology and 5 papers in Obstetrics and Gynecology. Recurrent topics in Tom Ehlen's work include Ovarian cancer diagnosis and treatment (9 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Cervical Cancer and HPV Research (4 papers). Tom Ehlen is often cited by papers focused on Ovarian cancer diagnosis and treatment (9 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Cervical Cancer and HPV Research (4 papers). Tom Ehlen collaborates with scholars based in Canada, United States and United Kingdom. Tom Ehlen's co-authors include Gavin Stuart, Ignace Vergote, N.S. Reed, Gunnar B. Kristensen, Antonio Casado, Frédéric Amant, Corneel Coens, René H.M. Verheijen, Nick Johnson and César Mendiola and has published in prestigious journals such as New England Journal of Medicine, European Journal of Cancer and Obstetrics and Gynecology.

In The Last Decade

Tom Ehlen

15 papers receiving 2.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

2010 1.7k citations Ignace Vergote, Claes G. Tropé et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Tom Ehlen	1.8k	1.2k	904	448	186	15	2.3k
T Maggino	1.5k 0.8×	679 0.6×	1.6k 1.7×	367 0.8×	318 1.7×	107	2.6k
Elisabeth Åvall‐Lundqvist	973 0.5×	683 0.6×	1.1k 1.3×	1.3k 2.8×	212 1.1×	76	2.7k
Bengt Sorbe	1.5k 0.8×	761 0.7×	1.6k 1.7×	634 1.4×	306 1.6×	133	3.0k
Christer Borgfeldt	829 0.5×	390 0.3×	813 0.9×	365 0.8×	101 0.5×	95	2.0k
Rolland J. Barrett	1.3k 0.7×	1.0k 0.9×	2.6k 2.9×	803 1.8×	311 1.7×	33	3.5k
Giorgia Mangili	2.4k 1.3×	1.1k 0.9×	1.4k 1.5×	529 1.2×	330 1.8×	211	4.0k
Ilana Cass	1.5k 0.8×	458 0.4×	856 0.9×	625 1.4×	175 0.9×	69	2.4k
Lene Lundvall	731 0.4×	530 0.5×	456 0.5×	210 0.5×	105 0.6×	51	1.6k
Susan A. Davidson	1.1k 0.6×	426 0.4×	444 0.5×	847 1.9×	244 1.3×	57	2.5k
Roberto Montera	730 0.4×	531 0.5×	630 0.7×	182 0.4×	82 0.4×	76	1.5k

Countries citing papers authored by Tom Ehlen

Since Specialization

Citations

This map shows the geographic impact of Tom Ehlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Ehlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Ehlen more than expected).

Fields of papers citing papers by Tom Ehlen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Ehlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Ehlen. The network helps show where Tom Ehlen may publish in the future.

Co-authorship network of co-authors of Tom Ehlen

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Ehlen. A scholar is included among the top collaborators of Tom Ehlen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Ehlen. Tom Ehlen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Vergote, Ignace, Corneel Coens, Matthew Nankivell, et al.. (2019). Neoadjuvant Chemotherapy Versus Debulking Surgery in Advanced Tubo-Ovarian Cancers: Pooled Analysis of Individual Patient Data From the EORTC 55971 and CHORUS Trials. Obstetrical & Gynecological Survey. 74(3). 156–158. 30 indexed citations

Vergote, Ignace, Corneel Coens, Gunnar B. Kristensen, et al.. (2016). Meta-analysis of the randomized EORTC and chorus neoadjuvant versus primary debulking trials in advanced tubo-ovarian cancer.. 2 indexed citations

Ward, Rabab, Dirk van Niekerk, Dianne Miller, et al.. (2015). Quantification of confocal fluorescence microscopy for the detection of cervical intraepithelial neoplasia. BioMedical Engineering OnLine. 14(1). 96–96. 23 indexed citations

MacAulay, Calum, Catherine F. Poh, J. Scott Durham, et al.. (2013). Fluorescence Visualization and Imaging: A Tool for Improving Patient Outcomes for Oral and (Hopefully) Other Cancers. JW4A.3–JW4A.3. 1 indexed citations

Brotto, Lori A., Mark Carey, Tom Ehlen, et al.. (2012). A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer. Gynecologic Oncology. 125(2). 320–325. 191 indexed citations

Salvador, Shannon, Cheng‐Han Lee, Trevor Cohen, et al.. (2012). The role of the fallopian tube in ovarian cancer.. PubMed. 10(5). 296–306. 67 indexed citations

Vergote, Ignace, Frédéric Amant, Gunnar B. Kristensen, et al.. (2011). Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer. European Journal of Cancer. 47. S88–S92. 110 indexed citations

Kwon, Janice S., Dianne Miller, Tom Ehlen, et al.. (2011). The significance of surgical staging in intermediate-risk endometrial cancer. Gynecologic Oncology. 122(1). 50–54. 11 indexed citations

Verleye, Leen, Petronella B. Ottevanger, Gunnar B. Kristensen, et al.. (2010). Quality of pathology reports for advanced ovarian cancer: Are we missing essential information?. European Journal of Cancer. 47(1). 57–64. 27 indexed citations

10.

Vergote, Ignace, Claes G. Tropé, Frédéric Amant, et al.. (2010). Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer. New England Journal of Medicine. 363(10). 943–953. 1719 indexed citations breakdown →

11.

Shadeo, Ashleen, Raj Chari, Kim M. Lonergan, et al.. (2008). Up regulation in gene expression of chromatin remodelling factors in cervical intraepithelial neoplasia. BMC Genomics. 9(1). 64–64. 28 indexed citations

12.

Ehlen, Tom, P. Hoskins, David F. Miller, et al.. (2005). A pilot phase 2 study of oregovomab murine monoclonal antibody to CA125 as an immunotherapeutic agent for recurrent ovarian cancer. International Journal of Gynecological Cancer. 15(6). 1023–1034. 60 indexed citations

13.

Ehlen, Tom, P. Hoskins, David S. Miller, et al.. (2005). A pilot phase 2 study of oregovomab murine monoclonal antibody to CA125 as an immunotherapeutic agent for recurrent ovarian cancer. International Journal of Gynecological Cancer. 15(6). 1023–1034. 3 indexed citations

14.

Benedet, J.L., et al.. (1997). Basal cell carcinoma of the vulva: Clinical features and treatment results in 28 patients. Obstetrics and Gynecology. 90(5). 765–768. 26 indexed citations

15.

Ehlen, Tom, et al.. (1989). Posthysterectomy carcinoma of the fallopian tube presenting as vaginal adenocarcinoma: A case report. Gynecologic Oncology. 33(3). 382–385. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact